Pfizer, anemia drugs, Chinese scientists and more—FiercePharmaAsia by Angus Liu Friday, August 23, 2019 Pfizer's mature drugs plunged in China. AZ and GSK race their oral anemia drugs to Asia. Biotech leaders worry IP crackdown will hurt collaboration.
Neopharma snaps up Lupin's sterile injectables business in Japan by Eric Palmer Thursday, August 22, 2019 Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin.
Neopharma snatches Dr. Reddy's API business by Eric Palmer Monday, October 15, 2018 India’s Dr. Reddy’s Laboratories says it will unload an API manufacturing plant to the Middle East-based Neopharma.
Dr. Reddy's sells antibiotics plant to Abu Dhabi-based Neopharma by Eric Palmer Monday, October 1, 2018 Dr. Reddy’s, which is trying to slim down in the face of regulatory issues, is selling its U.S. antibiotics plant to UAE-based Neopharma.
UAE’s Neopharma and ASKA of Japan to build drug plant in India in $53M JV by Joseph Keenan Thursday, May 3, 2018 Neopharma and ASKA Pharmaceuticals entered a joint venture to build a $53 million pharmaceutical manufacturing facility in India.
FiercePharmaAsia—Celgene’s $1.4B Beigene deal, Neopharma expands by Angus Liu Friday, July 7, 2017 Celgene buys Beigene’s PD-1 inhibitor, Fosun stumbles over rumors about its chairman, Neopharma expands in Japan and Abu Dhabi, and more.
Neopharma buys plant in Japan, will build one in Middle East by Eric Palmer Wednesday, July 5, 2017 UAE-based Neopharma plans to build a $100 million plant in Abu Dhabi after recently picking up a plant in Japan.
